retatrutide latest trial results Nearly 30% average weight loss from a weekly injection., could represent the next major step in obesity treatment, but it remains investigational, and long-term safety, monitoring and Lilly's triple agonist achieves 16.8%
Pay in 4 interest-free payments of $5.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27



















